Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease—A single center experience-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease—A single center experience

Published:2020-10-24 Issue:2 Volume:25 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Kogel Friederike¹,Hakimeh Dani¹,Sodani Pietro¹,Lang Peter¹²,Kühl Jörn‐Sven³,Hundsdoerfer Patrick⁴⁵⁶,Künkele Annette¹⁷⁸⁹,Eggert Angelika¹⁷⁸⁹,Oevermann Lena¹⁷⁸⁹^ORCID,Schulte Johannes H.¹⁷⁸⁹

Affiliation:

1. Department of Pediatric Hematology and Oncology Charité ‐ Universitätsmedizin Berlin Berlin Germany

2. Department of Pediatric Hematology and Oncology University Hospital Tübingen Germany

3. Department of Pediatric Oncology, Hematology, and Hemostaseology University Hospital Leipzig Leipzig Germany

4. Department of Pediatric Oncology and Hematology Charité‐Universitätsmedizin Berlin Berlin Germany

5. Berlin Institute of Health Berlin Germany

6. Department of Pediatrics Helios‐Klinikum Berlin‐Buch Berlin Germany

7. Berliner Institut für Gesundheitsforschung (BIH) Berlin Germany

8. German Cancer Consortium (DKTK) Berlin Germany

9. German Cancer Research Center (DKFZ) Heidelberg Germany

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13892

Reference36 articles.

1. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease

2. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

3. Barriers to Hematopoietic Cell Transplantation Clinical Trial Participation of African American and Black Youth With Sickle Cell Disease and Their Parents

5. Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: A Multidimentional Review;Cell Transplantation;2024-01

2. HLA-identical sibling hematopoietic stem cell transplantation following reduced-toxicity myeloablative conditioning regimen in sickle cell disease;2023-05-03

3. Allogeneic Transplant and Gene Therapy;Hematology/Oncology Clinics of North America;2022-12

4. The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease;Clinical Transplantation;2022-08-19

5. Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease;Journal of Clinical Medicine;2022-07-03